SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-17-000009
Filing Date
2017-01-09
Accepted
2017-01-09 11:09:02
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTM. JAMES BARRETTNEA 14 GP, LTDNEA PARTNERS 14, L.P.NEW ENTERPRISE ASSOCIATES 14, L.P.PATRICK J. KERINSPETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 GROWTH EQUITY OPPORTUNITIES FUND III, LLC / AURINIA PHARMACEUTICALS INC. aurinia-sch13d_18019.htm SC 13D 421241
  Complete submission text file 0001072613-17-000009.txt   423178
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities Fund III, LLC (Filed by) CIK: 0001551055 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88628 | Film No.: 17516295
SIC: 2834 Pharmaceutical Preparations